検体有効性試験の世界市場レポート 2025年

検体有効性試験の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.3％で、57億6,000万米ドルに成長します。予測期間の成長は、職場における薬物検査需要の高まり、経口液検査の採用拡大、研究開発業務の増加、SVTの使用率の上昇、疼痛管理への応用拡大に起因します。予測期間における主な動向としては、技術の進歩、結果解釈のための人工知能の統合、製品の革新、パートナーシップの増加、外出先でのモニタリングのための携帯型検査機器の開発などが挙げられます。

薬物乱用の増加は、検体有効性試験（SVT）市場の拡大を促進すると予測されます。薬物乱用とは、医療目的以外で合法または非合法の物質を頻繁に、過剰に、または不適切に使用することを指します。薬物乱用の増加は、オピオイドの流行、メンタルヘルス課題の増加、治療・支援リソースへのアクセス制限、大衆文化における薬物使用の描写など、相互に関連する複数の要因に起因しています。SVT法は、pH、比重、クレアチニン値、温度などの様々なパラメータを分析することにより、不純物や物質の存在を検出するように設計されています。例えば、2023年10月、英国の政府機関であるOffice for Health Improvement and Disparitiesは、2021年4月～2022年3月までの間に、薬物およびアルコールに関するプログラムに関与する成人の数が前年の28万人から29万人に増加しました。さらに2024年10月、英国の政府機関である国家統計局は、イングランドとウェールズにおける薬物中毒関連の死亡者数が2023年には5,448人に達し、2022年に記録された4,907人から11.0％増加したことを明らかにしました。このように、薬物乱用の発生率の上昇が検体有効性試験市場の成長に寄与すると予想されます。

検体有効性試験市場の主要企業は、市場での地位を維持するために、高解像度尿中薬物検査プロファイルなどの革新的な製品の開発に注力しています。高解像度尿薬物検査プロファイルは、高度な検査のための高度な分析技術を採用しています。例えば、2022年7月、Mayo Clinic Laboratoriesは、処方オピオイド、アルコール、マリファナ、ニコチンなどの一般的な物質中毒患者を管理するための包括的な情報を医師に提供することを目的としたデータ駆動型尿薬物検査（UDT）プロファイルを発表しました。このアディクション・メディシン・モニタリング・プロファイル（Mayo ID ADMPU）は、米国アディクション医学会のガイドラインに準拠しており、オピオイド、ベンゾジアゼピン、覚せい剤、PCPなど、さまざまな薬物クラスの親薬物および代謝物を検出する感度と特異性が向上しています。高分解能・高精度の質量分析計と標的免疫測定法を利用したこのプロファイルは、ヘルスケア従事者に臨床的に適切な情報を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の検体有効性試験市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の検体有効性試験市場：成長率分析
• 世界の検体有効性試験市場の実績：規模と成長、2019～2024年
• 世界の検体有効性試験市場の予測：規模と成長、2024～2029年、2034年
• 世界の検体有効性試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の検体有効性試験市場：製品とサービス別、実績と予測、2019～2024年、2024～2029年、2034年
• 製品
• サービス
• 世界の検体有効性試験市場：検査タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床検査
• 迅速検査またはポイントオブケア検査
• 世界の検体有効性試験市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬物リハビリテーションセンター
• 薬物スクリーニング研究所
• 疼痛管理センター
• 刑事司法および法執行機関
• その他
• 世界の検体有効性試験市場：製品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬・アッセイキット
• 制御装置・キャリブレーター
• 検体採取装置
• 分析装置・機器
• 世界の検体有効性試験市場：サービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ラボ検査サービス
• ポイントオブケア検査サービス

第7章 地域別・国別分析

• 世界の検体有効性試験市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の検体有効性試験市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 検体有効性試験市場：競合情勢
• 検体有効性試験市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson and Company
• Laboratory Corporation
• Quest Diagnostics Incorporated
• Alere Inc.
• Clinical Reference Laboratory Inc.
• Precision Diagnostics
• ACM Global Laboratories
• Millennium Health
• Omega Laboratories Inc.
• Dominion Diagnostics
• CannAmm
• Sciteck Inc.
• Starplex Scientific Inc.
• Vision Diagnostics Inc.
• Premier Biotech Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 検体有効性試験市場2029：新たな機会を提供する国
• 検体有効性試験市場2029：新たな機会を提供するセグメント
• 検体有効性試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Specimen Validity Testing (SVT) is a crucial process utilized to evaluate the integrity and authenticity of biological specimens, including urine, blood, saliva, or hair samples, collected for drug testing or clinical analysis. SVT scrutinizes diverse parameters such as pH, creatinine levels, specific gravity, and the presence of common masking agents such as oxidizing adulterants, nitrites, glutaraldehyde, and pyridinium chlorochromate.

Within the specimen validity testing market, products and services are the main offerings. Products encompass assay kits, reagents, calibrators, and disposables employed in the testing procedure to identify any adulteration, dilution, or substitution in urine samples. Various testing types include laboratory testing and rapid or point-of-care testing, catering to a range of end-users such as drug rehabilitation centers, drug screening laboratories, pain management centers, criminal justice and law enforcement agencies, among others.

The specimen validity testing market research report is one of a series of new reports from The Business Research Company that provides specimen validity testing market statistics, including the specimen validity testing industry global market size, regional shares, competitors with a specimen validity testing market share, detailed specimen validity testing market segments, market trends, and opportunities, and any further data you may need to thrive in the specimen validity testing industry. This specimen validity testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The specimen validity testing market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $4.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.

The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.

The growing issue of drug abuse is anticipated to drive the expansion of the specimen validity testing (SVT) market. Drug abuse refers to the frequent, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. The rise in drug abuse can be attributed to multiple interrelated factors, including the opioid epidemic, increasing mental health challenges, limited access to treatment and support resources, and portrayals of drug use in popular culture. SVT methods are designed to detect the presence of impurities and substances by analyzing various parameters such as pH, specific gravity, creatinine levels, and temperature. For example, in October 2023, the Office for Health Improvement and Disparities, a UK government agency, reported an increase in adult interactions with drug and alcohol programs, from 0.28 million in the previous year to 0.29 million between April 2021 and March 2022. Furthermore, in October 2024, the Office for National Statistics, a UK government body, revealed that drug poisoning-related deaths in England and Wales reached 5,448 in 2023, marking an 11.0% increase from the 4,907 deaths recorded in 2022. As a result, the rising incidence of drug abuse is expected to contribute to the growth of the specimen validity testing market.

Key players in the specimen validity testing market are focused on developing innovative products such as high-resolution urine drug testing profiles to maintain their market position. A high-resolution urine drug testing profile employs advanced analytical techniques for sophisticated testing. For instance, in July 2022, Mayo Clinic Laboratories introduced a data-driven urine drug testing (UDT) profile aimed at providing physicians with comprehensive information to manage patients addicted to common substances such as prescription opioids, alcohol, marijuana, and nicotine. This addiction medicine monitoring profile (Mayo ID ADMPU) complies with the American Society of Addiction Medicine's guidelines and offers enhanced sensitivity and specificity to detect parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. Utilizing high-resolution, accurate mass spectrometry and targeted immunoassay testing, the profile delivers clinically relevant information for healthcare providers.

In November 2024, SPT Labtech, a UK-based company specializing in the design and manufacturing of automated laboratory instruments, formed a partnership with ICE Bioscience. This collaboration aims to advance drug discovery by leveraging state-of-the-art drug screening and automation technologies. By improving assay development and expanding research capabilities, the partnership seeks to drive innovation in the pharmaceutical industry. ICE Bioscience, based in China, is a provider of drug screening platforms.

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd.

North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the specimen validity testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specimen validity testing market includes revenues earned by entities by creatinine testing, pH testing, adulterant testing, and specific gravity measurement and related specimen collection containers, urine test strips, adulterant detection kits, and temperature strips. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specimen Validity Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specimen validity testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for specimen validity testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The specimen validity testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Products; Service
• 2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing
• 3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users
• Subsegments:
• 1) By Products: Reagents And Assay Kits; Controls And Calibrators; Specimen Collection Devices; Analyzers And Instruments
• 2) By Service: Laboratory Testing Services; Point-Of-Care Testing Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers ; Medline Industries Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Specimen Validity Testing Market Characteristics

3. Specimen Validity Testing Market Trends And Strategies

4. Specimen Validity Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Specimen Validity Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Specimen Validity Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Specimen Validity Testing Market Growth Rate Analysis
• 5.4. Global Specimen Validity Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Specimen Validity Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Specimen Validity Testing Total Addressable Market (TAM)

6. Specimen Validity Testing Market Segmentation

• 6.1. Global Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Products
• Service
• 6.2. Global Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing
• Rapid Or Point-Of-Care Testing
• 6.3. Global Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Rehabilitation Centers
• Drug Screening Laboratories
• Pain Management Centers
• Criminal Justice And Law Enforcement Agencies
• Other End-Users
• 6.4. Global Specimen Validity Testing Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Assay Kits
• Controls And Calibrators
• Specimen Collection Devices
• Analyzers And Instruments
• 6.5. Global Specimen Validity Testing Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing Services
• Point-Of-Care Testing Services

7. Specimen Validity Testing Market Regional And Country Analysis

• 7.1. Global Specimen Validity Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Specimen Validity Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Specimen Validity Testing Market

• 8.1. Asia-Pacific Specimen Validity Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Specimen Validity Testing Market

• 9.1. China Specimen Validity Testing Market Overview
• 9.2. China Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Specimen Validity Testing Market

• 10.1. India Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Specimen Validity Testing Market

• 11.1. Japan Specimen Validity Testing Market Overview
• 11.2. Japan Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Specimen Validity Testing Market

• 12.1. Australia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Specimen Validity Testing Market

• 13.1. Indonesia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Specimen Validity Testing Market

• 14.1. South Korea Specimen Validity Testing Market Overview
• 14.2. South Korea Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Specimen Validity Testing Market

• 15.1. Western Europe Specimen Validity Testing Market Overview
• 15.2. Western Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Specimen Validity Testing Market

• 16.1. UK Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Specimen Validity Testing Market

• 17.1. Germany Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Specimen Validity Testing Market

• 18.1. France Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Specimen Validity Testing Market

• 19.1. Italy Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Specimen Validity Testing Market

• 20.1. Spain Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Specimen Validity Testing Market

• 21.1. Eastern Europe Specimen Validity Testing Market Overview
• 21.2. Eastern Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Specimen Validity Testing Market

• 22.1. Russia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Specimen Validity Testing Market

• 23.1. North America Specimen Validity Testing Market Overview
• 23.2. North America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Specimen Validity Testing Market

• 24.1. USA Specimen Validity Testing Market Overview
• 24.2. USA Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Specimen Validity Testing Market

• 25.1. Canada Specimen Validity Testing Market Overview
• 25.2. Canada Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Specimen Validity Testing Market

• 26.1. South America Specimen Validity Testing Market Overview
• 26.2. South America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Specimen Validity Testing Market

• 27.1. Brazil Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Specimen Validity Testing Market

• 28.1. Middle East Specimen Validity Testing Market Overview
• 28.2. Middle East Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Specimen Validity Testing Market

• 29.1. Africa Specimen Validity Testing Market Overview
• 29.2. Africa Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Specimen Validity Testing Market Competitive Landscape And Company Profiles

• 30.1. Specimen Validity Testing Market Competitive Landscape
• 30.2. Specimen Validity Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Specimen Validity Testing Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. Laboratory Corporation
• 31.3. Quest Diagnostics Incorporated
• 31.4. Alere Inc.
• 31.5. Clinical Reference Laboratory Inc.
• 31.6. Precision Diagnostics
• 31.7. ACM Global Laboratories
• 31.8. Millennium Health
• 31.9. Omega Laboratories Inc.
• 31.10. Dominion Diagnostics
• 31.11. CannAmm
• 31.12. Sciteck Inc.
• 31.13. Starplex Scientific Inc.
• 31.14. Vision Diagnostics Inc.
• 31.15. Premier Biotech Inc.

32. Global Specimen Validity Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specimen Validity Testing Market

34. Recent Developments In The Specimen Validity Testing Market

35. Specimen Validity Testing Market High Potential Countries, Segments and Strategies

• 35.1 Specimen Validity Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Specimen Validity Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Specimen Validity Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer